Sign in
4

Changes in Ownership

GERON CORP Filed Acc 0000886744-13-000032

Options or other derivatives

  • EVP, R&D, Chief Med Officer acquired 470,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kelsey Stephen Michael · EVP, R&D, Chief Med Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2013-02-12 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +470,000 $1.51 2023-02-12 470,000 470,000 D
Loading xslF345X03/edgar.xml…